[go: up one dir, main page]

BR0014444A - Prv-1 gene and its use - Google Patents

Prv-1 gene and its use

Info

Publication number
BR0014444A
BR0014444A BR0014444-4A BR0014444A BR0014444A BR 0014444 A BR0014444 A BR 0014444A BR 0014444 A BR0014444 A BR 0014444A BR 0014444 A BR0014444 A BR 0014444A
Authority
BR
Brazil
Prior art keywords
gene
prv
sequence
encodes
protein
Prior art date
Application number
BR0014444-4A
Other languages
Portuguese (pt)
Inventor
Heike Pahl
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of BR0014444A publication Critical patent/BR0014444A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Patente de Invenção: "GENE PRV-1 E USO DO MESMO". Este documento descreve uma seq³ência de nucleotídeos que codifica a proteína PRV-1 e compreende essencialmente a seq³ência ID NN<0>: 1 e também um processo para a detecção deste gene [lacuna] o mRNA codificado por este gene e o polipeptídeo codificado por este gene.Invention Patent: "GENE PRV-1 AND USE OF THE SAME". This document describes a nucleotide sequence that encodes the PRV-1 protein and essentially comprises the sequence ID NN <0>: 1 and also a process for the detection of this gene [gap] the mRNA encoded by this gene and the polypeptide encoded by it gene.

BR0014444-4A 1999-09-30 2000-09-29 Prv-1 gene and its use BR0014444A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (en) 1999-09-30 1999-09-30 The PRV-1 gene and its use
PCT/EP2000/009594 WO2001023554A1 (en) 1999-09-30 2000-09-29 The prv-1 gene and use thereof

Publications (1)

Publication Number Publication Date
BR0014444A true BR0014444A (en) 2002-06-11

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014444-4A BR0014444A (en) 1999-09-30 2000-09-29 Prv-1 gene and its use

Country Status (21)

Country Link
EP (1) EP1220920A1 (en)
JP (1) JP2003510077A (en)
KR (1) KR20020047191A (en)
CN (1) CN1377408A (en)
AU (1) AU1132401A (en)
BG (1) BG106554A (en)
BR (1) BR0014444A (en)
CA (1) CA2387702A1 (en)
CZ (1) CZ20021094A3 (en)
DE (1) DE19947010A1 (en)
EA (1) EA200200286A1 (en)
EE (1) EE200200168A (en)
HR (1) HRP20020269A2 (en)
HU (1) HUP0203080A2 (en)
IL (1) IL148770A0 (en)
MX (1) MXPA02002800A (en)
NO (1) NO20021498L (en)
PL (1) PL354184A1 (en)
SK (1) SK4262002A3 (en)
WO (1) WO2001023554A1 (en)
ZA (1) ZA200202379B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
EP3594239B1 (en) 2012-05-21 2024-10-30 F. Hoffmann-La Roche AG Methods for improving safety of blood-brain barrier transport
EP3638774B1 (en) * 2017-06-14 2024-08-07 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0991757A1 (en) * 1997-05-06 2000-04-12 ZymoGenetics Novel tumor antigens
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19849044A1 (en) * 1998-10-23 2000-04-27 Univ Ludwigs Albert New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies
EP1141285A2 (en) * 1998-12-16 2001-10-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
CN1377408A (en) 2002-10-30
IL148770A0 (en) 2002-09-12
ZA200202379B (en) 2003-10-29
DE19947010A1 (en) 2001-04-05
PL354184A1 (en) 2003-12-29
HRP20020269A2 (en) 2003-06-30
SK4262002A3 (en) 2002-09-10
HUP0203080A2 (en) 2002-12-28
AU1132401A (en) 2001-04-30
BG106554A (en) 2003-01-31
WO2001023554A1 (en) 2001-04-05
MXPA02002800A (en) 2002-07-22
NO20021498D0 (en) 2002-03-26
EE200200168A (en) 2003-04-15
JP2003510077A (en) 2003-03-18
CA2387702A1 (en) 2001-04-05
CZ20021094A3 (en) 2002-06-12
EP1220920A1 (en) 2002-07-10
NO20021498L (en) 2002-05-23
KR20020047191A (en) 2002-06-21
EA200200286A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
CY1106806T1 (en) DNA AND HUMAN TSLP POLYPEPTIDES
EP1067182A3 (en) Secretory protein or membrane protein
DE50112802D1 (en) PEPTIDES, THEIR PREPARATION AND USE OF THE BINDING OF IMMUNE LOBULINS
BR9909918A (en) Method for the release of a physiologically active growth hormone or protein cytokine, peptide or polypeptide to a non-human vertebrate
ATE495247T1 (en) CHROMOPROTEIN AND FLUOROPROTEINS
BR9902377A (en) Composition for toner and processes for it.
DK1028744T3 (en) Neuronal applications of BMP-11
WO2001046260A3 (en) Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof
BR0214542A (en) Host cell, expression system, and processes for preparing a host cell and a target protein
BR0014444A (en) Prv-1 gene and its use
AU762955C (en) Methods and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
DK0773999T3 (en) OR-1, an orphan receptor belonging to the nuclear receptor family
BR9915537A (en) Prv-1 gene and its use
BR9908145A (en) Melamine cooling process
NO20014691D0 (en) Seat-specific, isotope-labeled proteins, amino acids and biochemical precursors for such
WO2004003170A3 (en) Agents capable of inhibiting ras and uses thereof
ATE328082T1 (en) SHORTENED BARD1 PROTEIN AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
DK1360306T3 (en) DNA sequence of the enzyme phospholipase A1 from ciliate Tetrahymena and its use
EP0911408A3 (en) DNA coding for serine/threonine kinase
ITRM950434A0 (en) POLYPEPTIDE FOR THE REPAIR OF GENETIC INFORMATION, NUCLEOTIDE SEQUENCE THAT CODES FOR IT AND PROCEDURE FOR ITS PREPARATION.
GB0113920D0 (en) Composition
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
BR0100232A (en) Levodione reductase gene and use of it
BR9912183A (en) Angiotensin receptor, preparation and application
EP1348964A3 (en) Schizophrenia related gene

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]